TD Private Client Wealth’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
TD Private Client Wealth's RGEN Position: Q1 2026 in Review
TD Private Client Wealth increased its Repligen (RGEN) stake by 110% in Q1 2026, buying an estimated $1.54K and bringing the position to 21 shares worth $2.47K. The position accounts for ﹤0.01% of the portfolio, ranked #1278.
TD Private Client Wealth first reported a position in RGEN in Q2 2020 and has held it in 24 quarters since. The position peaked at $88.4K in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- TD Private Client Wealth held 21 shares of Repligen worth $2.47K as of Q1 2026.
- TD Private Client Wealth bought 11 Repligen shares in Q1 2026, an estimated $1.54K.
- Repligen made up ﹤0.01% of TD Private Client Wealth's portfolio in Q1 2026, its #1278 holding.
- TD Private Client Wealth first reported a position in Repligen in Q2 2020 and has held it in 24 quarters since.
- TD Private Client Wealth's Repligen position peaked at $88.4K in Q3 2021.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.